Table 2.
Parameter | CTL | HYPER | HYPO | ANOVA |
N | 30 | 46 | 23 | <0.0001 |
TG (mmol/L) | 1.14 ± 0.12 | 0.73 ± 0.06**,††† | 1.74 ± 0.09*** | <0.0001 |
TChol (mmol/L) | 4.58 ± 0.15 | 2.72 ± 0.14***,††† | 6.16 ± 0.24*** | <0.0001 |
LDL-C (mmol/L) | 2.40 ± 0.16 | 1.41 ± 0.09***,††† | 3.66 ± 0.18*** | <0.0001 |
HDL-C (mmol/L) | 1.56 ± 0.06 | 0.99 ± 0.04*** | 1.74 ± 0.07††† | <0.0001 |
NEFA (mmol/L) | 0.361 ± 0.03 | 0.617 ± 0.05*** | 0.425 ± 0.03††† | <0.0001 |
Results are expressed as average ± SEM for the four groups indicated as control (CTL), hyperthyroid (HYPER) and hypothyroid (HYPO) where TG = plasma triglyceride, TChol = total cholesterol, LDL-C = LDL cholesterol, HDL-C = HDL cholesterol and NEFA = non-esterified fatty acids. Significance was calculated by ANOVA with Bonferroni post-hoc test where differences vs. control (CTL) group are indicated as *P < 0.05,**P < 0.01,***P < 0.001; and differences between hyperthyroid and hypothyroid are indicated as †p < 0.05, ††p < 0.01, †††p < 0.001.